Clinical trial · Interventional
Feasibility of Auricular Acupressure for Appetite and Weight in Patients With Stage II-IV Gastric, Esophageal, and Pancreatic Cancer
A Randomized Controlled Trial Testing the Effects of an Acupressure Intervention on Appetite and Weight in Patients With Gastric, Esophageal, and Pancreatic Cancer: A Pilot and Feasibility Study
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): Study closed per SRC Low Accrual Policy.
Summary
Brief summary (as posted)
This clinical trial evaluates the feasibility and acceptability of acupressure to the ear (auricular) to address appetite and weight in patients with stage II-IV gastric, esophageal, or pancreatic cancer. Cancer anorexia, the abnormal loss of appetite, directly leads to cancer-associated weight loss (cachexia) through malnourishment, reduced caloric intake, treatment side-effects, and other modifiable risk factors. Cachexia prolongs length of hospital stay for patients, negatively impacts treatment tolerance and adherence, and reduces overall patient quality of life. Auricular acupressure is a form of micro-acupuncture that exerts its effect by stimulating the central nervous system using adhesive taped pellets applied to specific locations on the external ear. The use of these pellets to deliver auricular acupressure has been shown to improve pain, fatigue, insomnia, nausea and vomiting, depression, and quality of life in both cancer and non-cancer settings. Auricular acupressure is a safe, inexpensive, and non-invasive approach to addressing cancer-related symptoms and treatment side-effects and may be effective at improving appetite and weight loss in stage II-IV gastric, esophageal, and pancreatic cancer patients.
Conditions
Conditions (12)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Clinical Stage II Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage II Esophageal Squamous Cell Carcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage II Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage III Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage III Esophageal Squamous Cell Carcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage III Gastric Cancer AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage IV Esophageal Adenocarcinoma AJCC v8 | — | UNRESOLVED | — |
| Clinical Stage IV Esophageal Squamous Cell Carcinoma AJCC v8 |
Interventions
Interventions (4)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Acupressure Therapy | Procedure | — | UNRESOLVED |
| Best Practice | Other | — | UNRESOLVED |
| Biospecimen Collection | Procedure | — | UNRESOLVED |
| Questionnaire Administration | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Arm I (acupressure therapy)
- description
- Patients undergo auricular acupressure in addition to their usual care on study. Patients also undergo collection of blood samples on study.
- interventionNames
- Procedure: Acupressure Therapy
- Other: Best Practice
- Procedure: Biospecimen Collection
- Other: Questionnaire Administration
- type
- ACTIVE_COMPARATOR
- label
- Arm II (usual care)
- description
- Patients receive usual care on study. Patients also undergo collection of blood samples on study.
- interventionNames
- Other: Best Practice
- Procedure: Biospecimen Collection
- Other: Questionnaire Administration
Primary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * 18-65 years of age * Stage II-IV gastric, esophageal, or pancreatic cancer * Appetite score on visual analog scale ≤ 70/100 * At least 60 days of planned systemic treatment, whether already initiated or scheduled to be initiated * Access to phone and electronic device for study contacts and questionnaires * Willing and able to attend 4 in-person auricular acupressure treatments at the Fred Hutch South Lake Union Clinic * Willing and able to perform 4 at-home self-applied treatments of auricular acupressure * Participants must not have received acupressure or acupuncture for low appetite within last 30 days * Participants must not be actively using corticosteroids, mirtazapine (Remeron), olanzapine (Zyprexa), or Marinol for appetite stimulation at baseline * Participants must be able to intake food orally and not require sole or supplemental intravenous nutrition at baseline * Participants must not have a history of physiological eating disorders (e.g., anorexia nervosa) in the last 3 years * Participants must not have a current known or diagnosed immunodeficiency * Participants must have an intact auricular pinna * Able to understand and willing to sign written informed consent in English
References
Publications (0)
Data not yet available